FOXM1 and hepatocellular carcinoma: In summary, our current investigation demonstrates that FVTF inhibits HCC cell stem properties by targeting DNMT1/miR-34a-5p/FoxM1 axis, and dysregulation of DNMT1, miR-34a-5p and FoxM1 expression is correlated with HCC recurrence and prognosis.